High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China

J Med Virol. 2016 Aug;88(8):1462-6. doi: 10.1002/jmv.24490. Epub 2016 Feb 24.

Abstract

It remains unclear if China's current HIV antibody testing algorithm misses a substantial number of HIV infected individuals. Of 196 specimens with indeterminate or negative results on HIV western blot (WB) retrospectively examined by HIV-1 nucleic acid test (NAT), 67.57% (75/111) of indeterminate WB samples, and 16.47% (14/85) of negative WB samples were identified as NAT positive. HIV-1 loads in negative WB samples were significantly higher than those in indeterminate WB samples. Notably, 86.67% (13/15) of samples with negative WB and double positive immunoassay results were NAT positive. The rate of HIV-1 infections missed by China's current HIV testing algorithm is unacceptably high. Thus, China should consider using NAT or integrating fourth generation ELISA into current only antibodies-based HIV confirmation. J. Med. Virol. 88:1462-1466, 2016. © 2016 Wiley Periodicals, Inc.

Keywords: China; HIV-1 nucleic acid test (NAT); enzyme-linked immunosorbent assays (ELISA); western blot (WB).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Serodiagnosis*
  • Adult
  • Algorithms*
  • Blotting, Western*
  • China / epidemiology
  • Delayed Diagnosis*
  • Enzyme-Linked Immunosorbent Assay / standards
  • False Negative Reactions
  • Female
  • HIV Antibodies / blood
  • HIV Infections / diagnosis*
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / genetics
  • HIV-1 / immunology
  • HIV-2 / genetics
  • HIV-2 / immunology
  • Humans
  • Immunoassay
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • RNA, Viral / isolation & purification
  • Retrospective Studies
  • Serologic Tests / methods
  • Serologic Tests / standards
  • Young Adult

Substances

  • HIV Antibodies
  • RNA, Viral